Annual report
2689.TEDINET S100Z3WT
Period2025-07-01 → 2026-06-30
Filed2026-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥126.6bn | 2025-07-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2025-07-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2025-07-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.8bn | 2025-07-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥46.7bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.9bn | at 2023-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.0bn | at 2022-06-30v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.6bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥13.1bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30v | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.1bn | at 2022-06-30v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.1bn | at 2022-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥865m | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥212m | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥591m | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥187.67 | 2025-07-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,203.27 | at 2026-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,068.59 | at 2025-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,922.58 | at 2024-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,712.19 | at 2023-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,513.91 | at 2022-06-30v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 28.0% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.8% | 2025-07-01 → 2026-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2024-07-01 → 2025-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2023-07-01 → 2024-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.6% | 2022-07-01 → 2023-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2021-07-01 → 2022-06-30v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,405 | at 2026-06-30 | Cons. | Number of employees |
| Employees | 1,393 | at 2025-06-30 | Cons. | Number of employees |
| Employees | 1,354 | at 2024-06-30v | Cons. | Number of employees |
| Employees | 1,317 | at 2023-06-30v | Cons. | Number of employees |
| Employees | 1,289 | at 2022-06-30v | Cons. | Number of employees |
| Revenue | ¥2.7bn | 2025-07-01 → 2026-06-30 | Standalone | Net sales |
| Revenue | ¥2.7bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2023-07-01 → 2024-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2022-07-01 → 2023-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2021-07-01 → 2022-06-30v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2025-07-01 → 2026-06-30 | Standalone | Operating income |
| Operating income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2025-07-01 → 2026-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥672m | 2023-07-01 → 2024-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥631m | 2022-07-01 → 2023-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-07-01 → 2022-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥995m | 2025-07-01 → 2026-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Income before income taxes |
| Net income | ¥934m | 2025-07-01 → 2026-06-30 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | ¥592m | 2023-07-01 → 2024-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥549m | 2022-07-01 → 2023-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥999m | 2021-07-01 → 2022-06-30v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.7bn | at 2026-06-30 | Standalone | Assets |
| Total assets | ¥10.5bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥8.5bn | at 2024-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2023-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2022-06-30v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2026-06-30 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2025-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.9bn | at 2026-06-30 | Standalone | Net assets |
| Net assets / equity | ¥5.4bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2024-06-30v | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2023-06-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.7bn | at 2022-06-30v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥681m | at 2026-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥157.57 | 2025-07-01 → 2026-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.4 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.31 | 2023-07-01 → 2024-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.25 | 2022-07-01 → 2023-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥164.46 | 2021-07-01 → 2022-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2025-07-01 → 2026-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-07-01 → 2024-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-07-01 → 2023-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-07-01 → 2022-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥992.17 | at 2026-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥917.19 | at 2025-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥815.07 | at 2024-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥809.18 | at 2023-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥775.62 | at 2022-06-30v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.1% | at 2026-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.7% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2024-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.1% | at 2023-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2025-07-01 → 2026-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.2% | 2024-07-01 → 2025-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2023-07-01 → 2024-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2022-07-01 → 2023-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2021-07-01 → 2022-06-30v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,250,000 | at 2026-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2024-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2023-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2022-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 45 | at 2026-06-30 | Standalone | Number of employees |
| Employees | 50 | at 2025-06-30 | Standalone | Number of employees |
| Employees | 51 | at 2024-06-30v | Standalone | Number of employees |
| Employees | 47 | at 2023-06-30v | Standalone | Number of employees |
| Employees | 41 | at 2022-06-30v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-07-01 → 2026-06-30 | ¥184m |
| Reconciling Itemsreconciling | depreciation | 2025-07-01 → 2026-06-30 | ¥24m |
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2026-06-30 | −¥1.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2026-06-30 | −¥1.9bn |
| Reconciling Itemsreconciling | segment assets | at 2026-06-30 | −¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2026-06-30 | −¥152m |
| Care Nursing Goodsreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥9m |
| Care Nursing Goodsreportable segment | employees | at 2026-06-30 | 150 pure |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥2.9bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥2.9bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥246,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2026-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥245m |
| Medical Equipmentreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥1.3bn |
| Medical Equipmentreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥684m |
| Medical Equipmentreportable segment | employees | at 2026-06-30 | 1026 pure |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥119.5bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥117.7bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥1.7bn |
| Medical Equipmentreportable segment | segment assets | at 2026-06-30 | ¥42.4bn |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥1.5bn |
| SPDreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥30m |
| SPDreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥22m |
| SPDreportable segment | employees | at 2026-06-30 | 184 pure |
| SPDreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥6.1bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥6.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥133m |
| SPDreportable segment | segment assets | at 2026-06-30 | ¥7.0bn |
| SPDreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥120m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-07-01 → 2026-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-07-01 → 2026-06-30 | ¥715m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2026-06-30 | ¥128.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2026-06-30 | ¥126.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-06-30 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2026-06-30 | ¥1.8bn |
| Reconciling Itemsreconciling | capex | 2024-07-01 → 2025-06-30 | ¥122m |
| Reconciling Itemsreconciling | depreciation | 2024-07-01 → 2025-06-30 | ¥22m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment assets | at 2025-06-30 | −¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2025-06-30 | −¥113m |
| Care Nursing Goodsreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥19m |
| Care Nursing Goodsreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥8m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥144,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2025-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥205m |
| Medical Equipmentreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥1.6bn |
| Medical Equipmentreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥571m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥115.9bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥114.3bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-06-30 | ¥42.7bn |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥1.8bn |
| SPDreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥27m |
| SPDreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥24m |
| SPDreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥5.7bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥5.6bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥129m |
| SPDreportable segment | segment assets | at 2025-06-30 | ¥6.0bn |
| SPDreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥114m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-07-01 → 2025-06-30 | ¥603m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2025-06-30 | ¥124.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2025-06-30 | ¥122.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-06-30 | ¥49.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2025-06-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,719
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign currency translation adjustment | Prior1YearInstant | -4181000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | -11990000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 330797000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 545370000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 487121000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 668817000 | JPY |
| Non controlling interests | Prior1YearInstant | － | JPY |
| Non controlling interests | CurrentYearInstant | － | JPY |
| Net assets | Prior1YearInstant | 12255637000 | JPY |
| Net assets | CurrentYearInstant | 13061049000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 45871212000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 46653564000 | JPY |
| Net sales | Prior1YearDuration | 122702463000 | JPY |
| Net sales | CurrentYearDuration | 126595620000 | JPY |
| Cost of sales | Prior1YearDuration | 108793459000 | JPY |
| Cost of sales | CurrentYearDuration | 112416991000 | JPY |
| Gross profit | Prior1YearDuration | 13909004000 | JPY |
| Gross profit | CurrentYearDuration | 14178628000 | JPY |
| Directors compensations sga | Prior1YearDuration | 333159000 | JPY |
| Directors compensations sga | CurrentYearDuration | 328863000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 5427073000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 5581148000 | JPY |
| Bonuses sga | Prior1YearDuration | 1052163000 | JPY |
| Bonuses sga | CurrentYearDuration | 1077473000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 244645000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 246349000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 2450000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 2800000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YearDuration | 47960000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYearDuration | 45429000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -742000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 16360000 | JPY |
| Other sga | Prior1YearDuration | 4822340000 | JPY |
| Other sga | CurrentYearDuration | 5200374000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 11929049000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 12498800000 | JPY |
| Operating income | Prior1YearDuration | 1979954000 | JPY |
| Operating income | CurrentYearDuration | 1679828000 | JPY |
| Interest income noi | Prior1YearDuration | 1311000 | JPY |
| Interest income noi | CurrentYearDuration | 2489000 | JPY |
| Dividends income noi | Prior1YearDuration | 2746000 | JPY |
| Dividends income noi | CurrentYearDuration | 3280000 | JPY |
| Foreign exchange gains noi | Prior1YearDuration | 3035000 | JPY |
| Foreign exchange gains noi | CurrentYearDuration | 16275000 | JPY |
| Gain on investments in partnership noi | Prior1YearDuration | 3926000 | JPY |
| Gain on investments in partnership noi | CurrentYearDuration | － | JPY |
| Commission fee noi | Prior1YearDuration | 943000 | JPY |
| Commission fee noi | CurrentYearDuration | 1349000 | JPY |
| Insurance income noi | Prior1YearDuration | 2690000 | JPY |
| Insurance income noi | CurrentYearDuration | 3228000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |